Trials / Active Not Recruiting
Active Not RecruitingNCT07393204
Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL
Italian Real-world Study on Epcoritamab in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Andrés José Maria Ferreri · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study describes the effectiveness of epcoritamab outside the clinical trial setting in pts with DLBCL relapsed or refractory after 2 or more previous lines of therapy
Conditions
Timeline
- Start date
- 2025-12-10
- Primary completion
- 2026-12-10
- Completion
- 2026-12-10
- First posted
- 2026-02-06
- Last updated
- 2026-02-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07393204. Inclusion in this directory is not an endorsement.